1. Implication of biopharmaceutics and pharmacokinetics of rifampicin in variable bioavailability from solid oral dosage forms;Agrawal;Biopharm. Drug Dispos.,2005
2. Development and validation of a stability-indicating HPTLC method for analysis of anti-tubercular drugs;Ali;Acta Chromatogr.,2007
3. Reclassification of Amycolatopsis mediterranei DSM 46095 as Amycolatopsis rifamycinica sp nov;Bala;Int. J. Syst. Evol. Microbiol.,2004
4. Bacteriologic studies of rifampin, a new semi synthetic antibiotic;Calvin;J. Infect. Dis.,1969
5. Chin, F.S., Mansour, Y., Nick, B., Rebecca, B., Samira, B.L., Farideh, A.J., Morgan, D., 2009. In: Proceedings of the World Congress on Engineering, vol. II, London, UK.